Tan Yinfei, Timakhov Roman A, Rao Mamta, Altomare Deborah A, Xu Jinfei, Liu Zemin, Gao Qingshen, Jhanwar Suresh C, Di Cristofano Antonio, Wiest David L, Knepper Janice E, Testa Joseph R
Human Genetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Cancer Res. 2008 Mar 1;68(5):1296-302. doi: 10.1158/0008-5472.CAN-07-3218.
The oncogene v-akt was isolated from a retrovirus that induced murine thymic lymphomas. Transgenic mice expressing a constitutively activated form of the cellular homologue Akt2 specifically in immature T cells develop spontaneous thymic lymphomas. We hypothesized that tumors from these mice might exhibit oncogenic chromosomal rearrangements that cooperate with activated Akt2 in lymphomagenesis. Cytogenetic analysis revealed a recurrent clonal inversion of chromosome 6, inv(6), in thymic lymphomas from multiple transgenic founder lines, including one line in which 15 of 15 primary tumors exhibited this same rearrangement. Combined fluorescence in situ hybridization, PCR, and DNA sequence analyses showed that the distal inv(6) breakpoint resides at the T-cell receptor beta chain locus, Tcrb. The proximal breakpoint maps to a region near a locus comprising the linked homeobox/transcription factor genes Dlx5 and Dlx6. Expression analysis of genes translocated to the vicinity of the Tcrb enhancer revealed that Dlx5 and Dlx6 are overexpressed in tumors exhibiting the inv(6). Experimental overexpression of Dlx5 in mammalian cells resulted in enhanced cell proliferation and increased colony formation, and clonogenic assays revealed cooperativity when both Dlx5 and activated Akt2 were coexpressed. In addition, DLX5, but not DLX6, was found to be abundantly expressed in three of seven human T-cell lymphomas tested. These findings suggest that the Dlx5 can act as an oncogene by cooperating with Akt2 to promote lymphomagenesis.
致癌基因v-akt是从一种诱导小鼠胸腺淋巴瘤的逆转录病毒中分离出来的。在未成熟T细胞中特异性表达细胞同源物Akt2组成型激活形式的转基因小鼠会自发发生胸腺淋巴瘤。我们推测,这些小鼠的肿瘤可能表现出致癌性染色体重排,在淋巴瘤发生过程中与激活的Akt2协同作用。细胞遗传学分析显示,多个转基因奠基系的胸腺淋巴瘤中存在6号染色体的反复克隆性倒位,即inv(6),其中一个品系的15个原发性肿瘤中有15个都表现出相同的重排。荧光原位杂交、PCR和DNA序列分析相结合表明,inv(6)远端断点位于T细胞受体β链基因座Tcrb处。近端断点定位于一个包含连锁的同源框/转录因子基因Dlx5和Dlx6的基因座附近的区域。对易位到Tcrb增强子附近的基因进行表达分析发现,Dlx5和Dlx6在表现出inv(6)的肿瘤中过度表达。在哺乳动物细胞中实验性过表达Dlx5导致细胞增殖增强和集落形成增加,克隆形成试验显示,当Dlx5和激活的Akt2共表达时具有协同作用。此外,在检测的7例人类T细胞淋巴瘤中有3例发现DLX5大量表达,而DLX6未大量表达。这些发现表明,Dlx5可通过与Akt2协同作用促进淋巴瘤发生而发挥致癌基因的作用。